Pharmaceutical R&D trends and costs, Value chain paradigms, Basic v/s translational research, Investment needs, and COVID 19
Prof. Kenneth Kaitin is a professor of Public Health and Medicine at Tufts School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University in Shanghai, and a consultant to the U.S. Department of Defense on bioterror countermeasures. Ken’s research focuses on the economic, scientific, regulatory, and political factors that affect pharmaceutical development.

---

This episode is sponsored by
· Anchor: The easiest way to make a podcast. https://anchor.fm/app

---

Send in a voice message: https://anchor.fm/scientificsense/message
Support this podcast: https://anchor.fm/scientificsense/support